All Metrics
NRC Valuation Metrics
NRC Stock Price Metrics
NRC Dividend Metrics
NRC Growth Rate Metrics
NRC Discounted Cash Flow Metrics
| Fair Value Price | $13.24 |
| Margin of Safety | (36.37%) |
NRC Revenue Metrics
NRC PE Ratio Metrics
| PE Ratio | 52.33 |
| PE Ratio Avg TTM | 26.61 |
| PE Ratio Avg 3Y | 25.07 |
| Current VS TTM Avg | +96.69% |
| Current VS 3Y Avg | +108.75% |
| Current VS 5Y Avg | +93.05% |
NRC PS Ratio Metrics
| PS Ratio | 3.29 |
| PS Ratio Avg TTM | 2.63 |
| PS Ratio Avg 3Y | 4.02 |
| Current VS TTM Avg | +25.13% |
| Current VS 3Y Avg | -18.23% |
| Current VS 5Y Avg | -37.68% |
NRC PB Ratio Metrics
| PB Ratio | 33.79 |
| PB Ratio Avg TTM | 22.61 |
| PB Ratio Avg 3Y | 15.93 |
| Current VS TTM Avg | +49.46% |
| Current VS 3Y Avg | +112.07% |
| Current VS 5Y Avg | +137.93% |
NRC Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 26.16 |
| PFCF Ratio Avg TTM | 29.32 |
| PFCF Ratio Avg 3Y | 30.82 |
| Current VS TTM Avg | -10.77% |
| Current VS 3Y Avg | -15.11% |
| Current VS 5Y Avg | -14.06% |
NRC Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 5.78 |
| Debt/Equity Ratio Avg TTM | 4.60 |
| Debt/Equity Ratio Avg 3Y | 2.35 |
| Current VS TTM Avg | +25.61% |
| Current VS 3Y Avg | +145.87% |
| Current VS 5Y Avg | +533.12% |
NRC PEG Ratio Metrics
| PEG Ratio | - |
| PEG Ratio Avg TTM | 2.52 |
| PEG Ratio Avg 3Y | 3.04 |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | - |
NRC FCF Yield
| FCF Yield | 3.82% |
| FCF Yield Avg TTM | 3.56% |
| FCF Yield Avg 3Y | 3.78% |
| Current VS TTM Avg | +7.21% |
| Current VS 3Y Avg | +1.07% |
| Current VS 5Y Avg | +6.88% |
NRC Earnings Yield
| Earnings Yield | 1.91% |
| Earnings Yield Avg TTM | 4.37% |
| Earnings Yield Avg 3Y | 4.69% |
| Current VS TTM Avg | -56.32% |
| Current VS 3Y Avg | -59.28% |
| Current VS 5Y Avg | -53.37% |
NRC EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 27.17 |
| Ev/Ebit Ratio Avg TTM | 17.26 |
| Ev/Ebit Ratio Avg 3Y | 17.93 |
| Current VS TTM Avg | +57.38% |
| Current VS 3Y Avg | +51.50% |
| Current VS 5Y Avg | +38.96% |
NRC EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 19.11 |
| Ev/Ebitda Ratio Avg TTM | 13.39 |
| Ev/Ebitda Ratio Avg 3Y | 15.09 |
| Current VS TTM Avg | +42.72% |
| Current VS 3Y Avg | +26.65% |
| Current VS 5Y Avg | +13.87% |
NRC EV/Assets Ratio Metrics
| Ev/Assets Ratio | 3.95 |
| Ev/Assets Ratio Avg TTM | 3.23 |
| Ev/Assets Ratio Avg 3Y | 4.93 |
| Current VS TTM Avg | +22.39% |
| Current VS 3Y Avg | -19.86% |
| Current VS 5Y Avg | -32.30% |
NRC EV/Sales Ratio Metrics
| Ev/Sales Ratio | 3.83 |
| Ev/Sales Ratio Avg TTM | 3.17 |
| Ev/Sales Ratio Avg 3Y | 4.35 |
| Current VS TTM Avg | +20.99% |
| Current VS 3Y Avg | -12.05% |
| Current VS 5Y Avg | -29.61% |
NRC Current Ratio Metrics
| Current Ratio | 0.52 |
| Current Ratio Avg TTM | 0.57 |
| Current Ratio Avg 3Y | 0.54 |
| Current VS TTM Avg | -8.71% |
| Current VS 3Y Avg | -3.46% |
| Current VS 5Y Avg | -47.83% |
NRC Quick Ratio Metrics
| Quick Ratio | 0.52 |
| Quick Ratio Avg TTM | 0.57 |
| Quick Ratio Avg 3Y | 0.54 |
| Current VS TTM Avg | -8.71% |
| Current VS 3Y Avg | -3.46% |
| Current VS 5Y Avg | -47.56% |
NRC ROIC Metrics
| ROIC | 14.36% |
| ROIC Avg 3Y | 26.82% |
| ROIC Avg 5Y | 29.14% |
| Current VS 3Y Avg | -46.46% |
| Current VS 5Y Avg | -50.72% |
| Current VS 10Y Avg | -52.40% |
NRC Return on Assets Metrics
| ROA | 8.60% |
| ROA Avg TTM | 13.65% |
| ROA Avg 3Y | 19.24% |
| Current VS TTM Avg | -37.00% |
| Current VS 3Y Avg | -55.31% |
| Current VS 5Y Avg | -59.90% |
NRC Return on Equity Metrics
| ROE | 82.92% |
| ROE Avg TTM | 81.07% |
| ROE Avg 3Y | 67.39% |
| Current VS TTM Avg | +2.28% |
| Current VS 3Y Avg | +23.05% |
| Current VS 5Y Avg | +33.97% |
NRC Net Profit Margin Metrics
| Net Profit Margin | 9.26% |
| Net Profit Margin Avg TTM | 8.64% |
| Net Profit Margin Avg 3Y | 16.34% |
| Current VS TTM Avg | +7.13% |
| Current VS 3Y Avg | -43.34% |
| Current VS 5Y Avg | -54.59% |
Last Updated: Saturday, June 27, 2026
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green